Chronic bilirubin encephalopathy: diagnosis and outcome

Seminars in Fetal and Neonatal Medicine

Volumn 15, Issue 3, 2010, Pages 157-163

  Shapiro, Steven M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Auditory neuropathy dys synchrony; Bilirubin encephalopathy; BIND (bilirubin induced neurological dysfunction); Definition; Dystonia; Kernicterus

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE; BILIRUBIN; BOTULINUM TOXIN A; DIAZEPAM; TRIHEXYPHENIDYL;

ANAMNESIS; ARTICLE; BODY MOVEMENT; BRAIN DEPTH STIMULATION; COCHLEA PROSTHESIS; DECIDUOUS TOOTH; DENTAL CARE; DEVELOPMENTAL DISORDER; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVOKED BRAIN STEM AUDITORY RESPONSE; EYE MOVEMENT DISORDER; GASTROESOPHAGEAL REFLUX; GASTROSTOMY; GAZE; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; KERNICTERUS; LABORATORY TEST; LIFE EXPECTANCY; MEDICAL RESEARCH; MOTOR CONTROL; MOTOR DYSFUNCTION; MUSCLE HYPERTONIA; MUSCLE TONE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PHYSIOTHERAPY; SEIZURE; SLEEP DISORDER; SPEECH THERAPY; STOMACH FUNDOPLICATION; TOOTH DISEASE;

BRAIN DAMAGE, CHRONIC; DEVELOPMENTAL DISABILITIES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HUMANS; INFANT; KERNICTERUS; MAGNETIC RESONANCE IMAGING;

EID: 77953478352     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.12.004     Document Type: Article

References (46)

1. Kumada S., Hayashi M., Umitsu R., et al. Neuropathology of the dentate nucleus in developmental disorders. Acta Neuropathol (Berl) 94 (1997) 36-41
2. Ahdab-Barmada M., and Moossy J. Kernicterus reexamined. Pediatrics 71 (1983) 463-464
3. Haymaker W., Margles C., and Pentschew A. Pathology of kernicterus and posticteric encephalopathy. In: Swinyard C.A. (Ed). Kernicterus and its importance in cerebral palsy (1961), Charles C. Thomas, Springfield, IL 21-229
4. Blanc W.A., and Johnson L. Studies on kernicterus; relationship with sulfonamide intoxication, report on kernicterus in rats with glucuronyl transferase deficiency and review of pathogenesis. J Neuropath Exp Neurol 18 (1959) 165-189
5. Johnson L., Garcia M.L., Figueroa E., and Sarmiento F. Kernicterus in rats lacking glucuronyl transferase. Am J Dis Child 101 (1961) 322-349
6. Rose A.L., and Wisniewski H. Acute bilirubin encephalopathy induced with sulfadimethoxine in gunn rats. J Neuropathol Exp Neurol 38 (1979) 152-165
7. Johnston M.V., and Hoon Jr. A.H. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 15 (2000) 588-591
8. Claireaux A.E. Pathology of human kernicterus. p. 140-149 (1961), University of Toronto Press, Montreal
9. Ahdab-Barmada M., and Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropath Exp Neurol 43 (1984) 45-56
10. Malamud N. Pathogenesis of kernicterus in the light of its sequelae. In: Swinyard C.A. (Ed). Kernicterus and its importance in cerebral palsy (1961), Charles C. Thomas, Springfield, IL 230-246
11. Dublin W. Neurological lesions in erythroblastosis fetalis in relation to nuclear deafness. Am J Clin Pathol 21 (1951) 935-939
12. Gerrard J. Nuclear jaundice and deafness. J Laryngol Otol 66 (1952) 39-46
13. Kelemen G. Erythroblastosis fetalis. Pathologic report on the hearing organs of a newborn infant. Am Med Assoc Arch Otolaryngol 63 (1956) 392-398
14. Keino H., and Kashiwamata S. Critical period of bilirubin-induced cerebellar hypoplasia in a new sprague-dawley strain of jaundiced gunn rats. Neurosci Res 6 (1989) 209-215
15. Conlee J.W., and Shapiro S.M. Development of cerebellar hypoplasia in jaundiced gunn rats treated with sulfadimethoxine: a quantitative light microscopic analysis. Acta Neuropathologica 93 (1997) 450-460
16. Falcao A.S., Fernandes A., Brito M.A., Silva R.F., and Brites D. Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state. Acta Neuropathol (Berl) 112 (2006) 95-105
17. Falcao A.S., Fernandes A., Brito M.A., Silva R.F., and Brites D. Bilirubin-induced inflammatory response, glutamate release, and cell death in rat cortical astrocytes are enhanced in younger cells. Neurobiol Dis 20 (2005) 199-206
18. de Vries L.S., Lary S., and Dubowitz L.M.S. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk, low birth-weight infants. Pediatrics 76 (1985) 351-354
19. de Vries L.S., Lary S., Whitelaw A.G., and Dubowitz L.M. Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Hum Dev 15 (1987) 269-277
20. Johnson L., and Boggs T.R. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell G.B., Schaffer R., and Sionpoulous A.P. (Eds). Phototherapy in the newborn: an overview (1974), National Academy of Sciences, Washington 122-149
21. Ostrow J.D., Pascolo L., and Tiribelli C. Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 54 (2003) 98-104
22. Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics 28 (1961) 870-876
23. Volpe J.J. Bilirubin and brain injury. In: Volpe J.J. (Ed). Neurology of the newborn. 3rd ed. (2001), WB Saunders, Philadelphia 490-514
24. Perlstein M.A. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 7 (1960) 665-687
25. Johnson L., Bhutani V.K., Karp K., Sivieri E.M., and Shapiro S.M. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 29 Suppl. 1 (2009) S25-S45
26. Shapiro S.M. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 25 (2005) 54-59
27. Larroche J.C. Kernicterus. In: Vinken P., and Bruyn G.W. (Eds). Handbook of clinical neurology (1968), North-Holland, Amsterdam 491-515
28. Byers R.K., Paine R.S., and Crothers B. Extrapyramidal cerebral palsy with hearing loss following erythroblastosis. Pediatrics 15 (1955) 248-254
29. Hyman C.B., Keaster J., Hanson V., et al. CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients. Am J Dis Child 117 (1969) 395-405
30. Naeye R.L. Amniotic fluid infections, neonatal hyperbilirubinemia and psychomotor impairment. Pediatrics 62 (1978) 497-503
31. Odell G.B., Storey G.N., and Rosenberg L.A. Studies in kernicterus. III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr 76 (1970) 12-21
32. Rubin R.A., Balow B., and Fisch R.O. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. J Pediatr 94 (1979) 601-604
33. Scheidt P.C. Toxicity to bilirubin in neonates: infant development during first year in relation to maximal neonatal serum bilirubin concentration. J Pediatr 92 (1977) 292-297
34. Bergman I., Hirsch R.P., Fria T.J., et al. Cause of hearing loss in the high-risk premature infant. J Pediatr 106 (1985) 95-101
35. Salamy A., Eldredge L., and Tooley W.H. Neonatal status and hearing loss in high-risk infants. J Pediatr 114 (1989) 847-852
36. Rance G., Beer D.E., Cone-Wesson B., et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 20 (1999) 238-252
37. Simmons J.L., and Beauchaine K.L. Auditory neuropathy: case study with hyperbilirubinemia. J Am Acad Audiol 11 (2000) 337-347
38. Powers K.M., Miller S., and Shapiro S.M. Exposure to excessive hyperbilirubinemia earlier in neurodevelopment is associated with auditory-predominant kernicterus subtype. In: 37th Annual Meeting of the Child Neurology Society. Santa Clara, CA. Annals of Neurology 64 Suppl.12 (2008) S105
39. Rance G., Barker E., Mok M., et al. Speech perception in noise for children with auditory neuropathy/dys-synchrony type hearing loss. Ear Hear 28 (2007) 351-360
40. Rance G., Barker E.J., Sarant J.Z., and Ching T.Y. Receptive language and speech production in children with auditory neuropathy/dyssynchrony type hearing loss. Ear Hear 28 (2007) 694-702
41. Shallop J.K., Peterson A., Facer G.W., Fabry L.B., and Driscoll C.L. Cochlear implants in five cases of auditory neuropathy: postoperative findings and progress. Laryngoscope 111 4 Pt 1 (2001) 555-562
42. Madden C., Hilbert L., Rutter M., Greinwald J., and Choo D. Pediatric cochlear implantation in auditory neuropathy. Otol Neurotol 23 (2002) 163-168
43. Peterson A., Shallop J., Driscoll C., et al. Outcomes of cochlear implantation in children with auditory neuropathy. J Am Acad Audiol 14 (2003) 188-201
44. Wilson B.A. Wilson reading system. 3rd ed. (1996), Wilson Language Training, Oxford, MA
45. Wilson reading system (2002), Education Commission of the States, Denver
46. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 1 (2004) 297-316